PTEN and neoplasm: To assess whether the cellular mechanism of the combined treatment was also applicable in the xenograft model, Western blotting was used to examine the tumor levels of total-PTEN, phospho-PTEN, pro-Caspase 3 and cleaved-Caspase 3.